Waters Corporation $WAT Position Lowered by Toth Financial Advisory Corp

Toth Financial Advisory Corp trimmed its position in Waters Corporation (NYSE:WAT) by 72.0% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 582 shares of the medical instruments supplier’s stock after selling 1,499 shares during the period. Toth Financial Advisory Corp’s holdings in Waters were worth $218,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of WAT. Mufg Securities Americas Inc. lifted its holdings in Waters by 9.0% during the 2nd quarter. Mufg Securities Americas Inc. now owns 2,957 shares of the medical instruments supplier’s stock worth $1,109,000 after buying an additional 243 shares during the last quarter. Van ECK Associates Corp lifted its stake in Waters by 27.2% during the second quarter. Van ECK Associates Corp now owns 29,056 shares of the medical instruments supplier’s stock worth $10,897,000 after purchasing an additional 6,222 shares during the last quarter. Nissay Asset Management Corp Japan boosted its holdings in Waters by 6.3% in the second quarter. Nissay Asset Management Corp Japan now owns 13,798 shares of the medical instruments supplier’s stock worth $5,175,000 after purchasing an additional 821 shares during the period. Wellington Management Group LLP boosted its holdings in Waters by 69.2% in the second quarter. Wellington Management Group LLP now owns 1,373,150 shares of the medical instruments supplier’s stock worth $514,986,000 after purchasing an additional 561,824 shares during the period. Finally, Boussard & Gavaudan Gestion Sas bought a new stake in Waters during the second quarter valued at $655,000. Institutional investors and hedge funds own 94.01% of the company’s stock.

Waters Price Performance

NYSE WAT opened at $414.55 on Friday. Waters Corporation has a 52 week low of $282.77 and a 52 week high of $426.22. The company has a current ratio of 1.86, a quick ratio of 1.29 and a debt-to-equity ratio of 0.32. The stock has a market cap of $40.73 billion, a price-to-earnings ratio of 103.38, a price-to-earnings-growth ratio of 2.41 and a beta of 1.19. The company has a 50-day moving average price of $387.53 and a two-hundred day moving average price of $348.45.

Waters (NYSE:WAT) last released its earnings results on Tuesday, August 4th. The medical instruments supplier reported $3.05 EPS for the quarter, beating the consensus estimate of $3.01 by $0.04. Waters had a net margin of 3.58% and a return on equity of 11.27%. The firm had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.62 billion. During the same quarter last year, the company earned $2.95 EPS. Waters’s quarterly revenue was up 113.3% on a year-over-year basis. Waters has set its Q3 2026 guidance at 3.950-4.050 EPS and its FY 2026 guidance at 14.450-14.650 EPS. Analysts forecast that Waters Corporation will post 14.56 EPS for the current year.

Insider Transactions at Waters

In other Waters news, Director Christopher A. Kuebler sold 3,626 shares of the company’s stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $397.94, for a total transaction of $1,442,930.44. Following the completion of the sale, the director directly owned 17,808 shares of the company’s stock, valued at approximately $7,086,515.52. This represents a 16.92% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.31% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently issued reports on the stock. Bank of America raised their price target on shares of Waters from $370.00 to $400.00 and gave the stock a “neutral” rating in a research report on Tuesday, June 2nd. Evercore reiterated an “outperform” rating and set a $420.00 price objective on shares of Waters in a research note on Wednesday, August 5th. Wells Fargo & Company raised their target price on shares of Waters from $370.00 to $400.00 and gave the stock an “equal weight” rating in a report on Wednesday, August 5th. Citigroup raised their target price on shares of Waters from $425.00 to $470.00 and gave the stock a “buy” rating in a report on Monday, August 10th. Finally, Stifel Nicolaus set a $420.00 target price on Waters in a research note on Wednesday, August 5th. Three research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and seven have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $424.35.

Waters Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.